In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

TenNor brings in $25mm via Series B

Executive Summary

Antibiotics start-up TenNor Therapeutics Ltd. raised $25mm in its Series B financing led by Northern Light Venture Capital, which was joined by returning shareholders BioVentures, WuXi PharmaTech Healthcare Fund I, Oriza Venture Capital, and Relativity Healthcare Fund.
Deal Industry
  • Biotechnology
    • Drug Discovery Tools
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies